SEC 13F Intelligence

Ghost Tree Capital, LLC / IMMU

Ghost Tree Capital, LLC’s Immunomedics Inc Position

Does Ghost Tree Capital, LLC own Immunomedics Inc (IMMU)? Not currently — the last reported position was 575.0K shares worth $20M in Q2 2020; the fund’s latest 13F (Q3 2024) no longer reports it.

Position Value
$20M
Q2 2020
Shares
575.0K
% of Portfolio
+5.38%
Quarters Held
7
position exited

Position History IMMU

Reported value by quarter
Q4 ’18: $11MQ4 ’18Q1 ’19: $15MQ1 ’19Q2 ’19: $8MQ2 ’19Q3 ’19: $10MQ3 ’19Q4 ’19: $11MQ4 ’19Q1 ’20: $14MQ1 ’20Q2 ’20: $20MQ2 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2020575.0K$20M+5.38%
Q1 20201.05M$14M+3.75%
Q4 2019500.0K$11M+2.00%
Q3 2019725.0K$10M+2.44%
Q2 2019600.0K$8M+1.74%
Q1 2019800.0K$15M+4.16%
Q4 2018800.0K$11M+4.00%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ghost Tree Capital, LLC’s full portfolio or all institutional holders of IMMU.